Spatial targeting of Bcl-2 on endoplasmic reticulum and mitochondria in cancer cells by lipid nanoparticles

Shalini Pandey1, Sohan Patil, Nirmalya Ballav

  • 1Department of Chemistry, Indian Institute of Science Education and Research (IISER)-Pune, Dr Homi Bhabha Road, Pashan, Pune, Maharashtra 411008, India.

Insights

Researchers developed targeted nanoparticles to inhibit the anti-apoptotic Bcl-2 protein in specific cellular locations. This approach revealed distinct cancer cell responses, paving the way for novel cancer therapeutics.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Nanotechnology

Background:

  • Proteins can exhibit diverse functions based on their sub-cellular localization, complicating cancer signaling pathways.
  • Understanding protein spatial distribution is crucial for developing effective cancer therapeutics.

Purpose of the Study:

  • To develop targeted nanoscale particles for spatial inhibition of the anti-apoptotic Bcl-2 protein.
  • To investigate the functional consequences of inhibiting Bcl-2 in the endoplasmic reticulum (ER) and mitochondria.

Main Methods:

  • Development of endoplasmic reticulum (ER) and mitochondria-targeted nanoscale particles.
  • Utilizing confocal microscopy and gel electrophoresis to confirm nanoparticle localization and target inhibition.
  • Employing HeLa cervical cancer cells to study cellular responses.

Main Results:

  • Nanoparticles selectively targeted and inhibited Bcl-2 in the ER and mitochondria of HeLa cells.
  • ER-localized Bcl-2 inhibition induced ER stress and autophagy.
  • Mitochondria-localized Bcl-2 inhibition triggered mitochondrial damage and apoptosis.

Conclusions:

  • Targeted inhibition of Bcl-2 at specific organelles elicits distinct cellular responses.
  • Nanoscale platforms offer potential as chemical biology tools to explore protein location-function relationships.
  • This approach could inform the development of next-generation cancer therapeutics.